← FDA Drug Approvals (Drugs@FDA)

CLOBETASOL PROPIONATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK SPECLT · Approved 2018-03-26

Drug application

FDA Application #

ANDA209004

Application type

Abbreviated New Drug Application (Generic)

Brand name

CLOBETASOL PROPIONATE

Generic name

CLOBETASOL PROPIONATE

Active ingredients

CLOBETASOL PROPIONATE

Dosage form

SPRAY

Route

TOPICAL

Marketing status

Discontinued

Sponsor

GLENMARK SPECLT

Manufacturer

Glenmark Pharmaceuticals Inc., USA

First approval

2018-03-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown